Company dossier

Concord Drugs

BSE:CONCORD · ISIN INE858L01010

Close: Unavailable
Daily change: N/A
Evidence state: Building

Dossier

Concord DrugsBSE:CONCORD

Coverage

Canonical documents: 5
Annual reports: 4
Financial results: 1
Presentations: 0
Call documents: 0
Coverage checks: 0/0
Open gaps: 0

Ticker research deskCONCORD dossier context attached

Missing something in CONCORD?

System checks can pass and your research need can still be missing. Tell us what you expected to find in business.

Concord Drugs

Business

Business evidence pack

Primary material for understanding Concord Drugs

Source documents

Business-model synthesis will be generated from the company's annual reports, investor presentations and conference-call material. Until that layer is reconciled, IndiaTicker shows the source pack instead of company-specific claims.

09 Sept 25

Annual Report 2025 - Concord Drugs LimitedBSE · annual report · 148 pages

VerifiedArchived copy

09 Sept 25

Concord Drugs Ltd - 538965 - Reg. 34 (1) Annual Report.BSE · annual report · 148 pages

VerifiedArchived copy

08 Sept 25

Concord Drugs Ltd - 538965 - Annual ReportBSE · annual report · 148 pages

VerifiedArchived copy

06 Sept 24

Annual Report 2024 - Concord Drugs LimitedBSE · annual report · 153 pages

VerifiedArchived copy

Keep your research close.

Concord Drugs

What should we find for CONCORD?

Business

Primary material for understanding Concord Drugs